SCHEMBL8097252

SCHEMBL8097252

CC(C)NC(=O)Nc1ccc(-c2nc(N)cc(C3(S(C)(=O)=O)CCC3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
PIK3CD O00329 6/20 0.39
ROCK2 O75116 2/20 0.38
LIMK1 P53667 1/20 0.37
PIK3CA P42336 3/20 0.37
GHSR Q92847 2/20 0.36
ATR Q13535 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP3A5 P20815 1/20 0.36
MTOR P42345 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8091781 0.98 CA12 (0.43) CA12CA1CA2CA9PIK3CD
SCHEMBL8098188 0.97 CA12 (0.44) CA12CA1CA2CA9PIK3CD
SCHEMBL8097556 0.90 PIK3CA (0.42) PIK3CDPIK3CAATRMTORKMT2A
SCHEMBL8081823 0.89 PIK3CD (0.42) PIK3CDPIK3CAEPHX2
SCHEMBL8089531 0.88 CA12 (0.43) CA12CA1CA2CA9PIK3CD
SCHEMBL8098293 0.88 PIK3CA (0.42) PIK3CDPIK3CAATRMTORKDM4E
SCHEMBL8103635 0.88 ATR (0.39) PIK3CDPIK3CAATRMTORKDM4E
SCHEMBL8097177 0.87 PIK3CD (0.39) CA12CA1CA2CA9PIK3CD
SCHEMBL8105807 0.87 PIK3CD (0.42) PIK3CDPIK3CAEPHX2
SCHEMBL8104038 0.86 CA12 (0.41) CA12CA1CA2CA9PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed